- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 669-683 of
1,371 results
2005 Exhibit: Public Version of 662016 7232016 Email Chain between J Reda and ...
Document
IPR2016-01582, No. 2005-85 Exhibit - Public Version of 662016 7232016 Email Chain between J Reda and V Dhanorkar (P.T.A.B. Nov. 16, 2016)
|
|
Cite Document
2060 Exhibit: JSN 2060 Marini et al, The effect of adjuvant prednisone combined wi...
Document
IPR2016-01582, No. 2060-139 Exhibit - JSN 2060 Marini et al, The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients wit...
|
|
Cite Document
2026 Exhibit: JSN 2026 Remington The Science and Practice of Pharmacy, 20th ed...
Document
IPR2016-01582, No. 2026-107 Exhibit - JSN 2026 Remington The Science and Practice of Pharmacy, 20th ed, pp 1363 1370 2000 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2049 Exhibit: JSN 2049 Blackard, Letters to the Editor, Journal of Urology, 146616...
Document
IPR2016-01582, No. 2049-128 Exhibit - JSN 2049 Blackard, Letters to the Editor, Journal of Urology, 14661621 1622 1991 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2048 Exhibit: JSN 2048 Altman et al, The Revised CONSORT Statement for Report...
Document
IPR2016-01582, No. 2048-127 Exhibit - JSN 2048 Altman et al, The Revised CONSORT Statement for Reporting Randomized Trials Explanation and Elaboration, Ann Intern Med, 134663 694 20...
|
|
Cite Document
2061 Exhibit: JSN 2061 Body, Low dose prednisone and increased risk of developm...
Document
IPR2016-01582, No. 2061-140 Exhibit - JSN 2061 Body, Low dose prednisone and increased risk of development of bone metastases, Annals of Oncology, 7643 645 1996 (P.T.A.B. Mar. 17, 201...
|
|
Cite Document
2067 Exhibit: JSN 2067 Palmer, Managing Hyperkalemia Caused by Inhibitors of th...
Document
IPR2016-01582, No. 2067-146 Exhibit - JSN 2067 Palmer, Managing Hyperkalemia Caused by Inhibitors of the ReninAngiotensinAldosterone System, NEJ, 351585 592 2004 (P.T.A.B. Mar. 17, 2...
|
|
Cite Document
2068 Exhibit: JSN 2068 Swartz and Dluhy, Corticosteroids Clinical Pharmacology a...
Document
IPR2016-01582, No. 2068-147 Exhibit - JSN 2068 Swartz and Dluhy, Corticosteroids Clinical Pharmacology and Therapeutic Use, Drugs, 16238 255 1978 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2114 Exhibit: JSN 2114 Williams et al, Objective Responses to Ketoconazole Thera...
Document
IPR2016-01582, No. 2114-191 Exhibit - JSN 2114 Williams et al, Objective Responses to Ketoconazole Therapy in Patients with Relapsed Progressive Prostatic Cancer, British Journal of Urology...
|
|
Cite Document
2027 Exhibit: JSN 2027 Rumohr and Chang, Current chemotherapeutic approache...
Document
IPR2016-01582, No. 2027-108 Exhibit - JSN 2027 Rumohr and Chang, Current chemotherapeutic approaches for androgen independent prostate cancer, Current Opinion in Investigational Drug...
|
|
Cite Document
2047 Exhibit: JSN 2047 Stamey et al, Prostate Specific Antigen As A Serum Marke...
Document
IPR2016-01582, No. 2047-126 Exhibit - JSN 2047 Stamey et al, Prostate Specific Antigen As A Serum Marker For Adenocarcinoma Of The Prostate, NEJM, 31715909 916 1987 (P.T.A.B. Mar. 1...
|
|
Cite Document
2166 Exhibit: JSN 2166 June 2, 2014 Notice of Allowance from prosecution history ...
Document
IPR2016-01582, No. 2166-235 Exhibit - JSN 2166 June 2, 2014 Notice of Allowance from prosecution history of438 patent (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2071 Exhibit: JSN 2071 Ryan et al, Abiraterone acetate plus prednisone versus pla...
Document
IPR2016-01582, No. 2071-150 Exhibit - JSN 2071 Ryan et al, Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy naive men with metastatic castration resista...
|
|
Cite Document
2095 Exhibit: JSN 2095 Zytiga Usage prednisone information
Document
IPR2016-01582, No. 2095-173 Exhibit - JSN 2095 Zytiga Usage prednisone information (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2109 Exhibit: JSN 2109 Hotte and Saad, Current management of castrate resistant...
Document
IPR2016-01582, No. 2109-186 Exhibit - JSN 2109 Hotte and Saad, Current management of castrate resistant prostate cancer, Current Oncology, 172S72 S79 2010 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
